Delivery Order SPE2DR25D1017-SPE2DR26F9CDY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Zymfentra 120 mg/ml pen kits, with a contract ceiling value of $1,503.56. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $12,676.16 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zymfentra 120 mg/ml pen kits. This competitive contract represents a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Zymfentra 120 mg/ml pen kits under a firm fixed-price contract with a ceiling value of $2,911.28. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 3, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,169.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits, with an ultimate completion date of December 31, 2025. This non-set-aside contract was competitively awarded on December 9, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,169.04 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for Zymfentra 120 mg/ml pen kits, with performance completion targeted for January 21, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The work will be performed at the vendor's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Zymfentra 120 mg/ml pen kits, with a ceiling value of $3,007.12 and a firm fixed price structure. This contract utilizes a non-competitive set-aside designation and is scheduled for completion by November 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for the supply of Zymfentra 120 mg/ml pen (2-pack units) on August 5, 2025, with an ultimate completion date of August 26, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Zymfentra 120 mg/ml pen kits, with a ceiling value of $3,169.04 and completion date of January 22, 2026. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical supply needs, with performance to be...
- The Defense Logistics Agency awarded a $1,584.52 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Zymfentra 120 mg/ml pen kits. This is a firm fixed price, competitively awarded contract with an ultimate completion date of December 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,455.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits on November 10, 2025, with an ultimate completion date of December 3, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CDYDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,584.52 firm fixed price delivery order on December 29, 2025, for Zymfentra 120 mg/ml pen kits, with a completion deadline of January 21, 2026. The contract was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract awards with DLA consistently involve competitively awarded delivery orders with firm fixed pricing, demonstrating its capability to meet military medical supply requirements. The current delivery order for Zymfentra represents a routine procurement of specialty medication within the company's broader role supporting DLA's Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/28/25 |